or
forgot password
  • cancer clinical trials in charlottesville, VA

  • Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Endometrial Cancer
    BIBF 1120 for Recurrent High-Grade Gliomas
    University of Virginia
    Charlottesville, Virginia 22908
    Glioblastoma, Gliosarcoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma
    Rapid Radiation Therapy for Painful Osseous Metastatic Disease
    University of Virginia
    Charlottesville, Virginia 22908
    Bone Metastases
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    University of Virginia
    Charlottesville, Virginia 22908
    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Lymphoma, Neurotoxicity, Therapy-related Toxicity
    Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation
    University of Virginia Center for Research in Reproduction
    Charlottesville, Virginia 22902
    Hyperandrogenemia, Polycystic Ovary Syndrome, Obesity
    Ovarian Contribution to Androgen Production in Adolescent Girls
    University of Virginia Center for Research in Reproduction
    Charlottesville, Virginia 22902
    Polycystic Ovary Syndrome, Obesity, Hyperandrogenism
    Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition in Normal and Hyperandrogenemic Adolescent Girls
    Center for Research in Reproduction
    Charlottesville, Virginia 22908
    Hyperandrogenemia, Polycystic Ovary Syndrome (PCOS)
    Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone in Hyperandrogenemic Adolescent Girls
    Center for Research in Reproduction, University of Virginia
    Charlottesville, Virginia 22908
    Polycystic Ovary Syndrome, Hyperandrogenism
    Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone in Early Pubertal Girls With and Without Hyperandrogenemia
    Center for Research in Reproduction, University of Virginia
    Charlottesville, Virginia 22908
    Polycystic Ovary Syndrome, Hyperandrogenism
    Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
    Center for Research in Reproduction, University of Virginia
    Charlottesville, Virginia 22908
    Polycystic Ovary Syndrome, Hyperandrogenism
    Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition in Early Pubertal Girls
    Center for Research in Reproduction, University of Virginia
    Charlottesville, Virginia 22908
    Hyperandrogenemia, Polycystic Ovary Syndrome
    Radiation Therapy in Treating Patients With Prostate Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexual Dysfunction
    Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma
    University of Virginia Health System / Human Immune Therapy Center
    Charlottesville, Virginia 22908
    Melanoma, Malignant Melanoma
    A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
    University of Virginia Health System
    Charlottesville, Virginia 22903
    CD27 Expressing B-cell Malignancies, CD27 Expressing Solid Tumors, Chronic Lymphocytic Leukemia, Burkett's Lymphoma, Mantle Cell Lymphoma, Primary Lymphoma of the Central Nervous System, Marginal Zone B Cell Lymphoma, Solid Tumor, Metastatic Melanoma, Renal (Clear) Cell Carcinoma, Hormone-refractory Prostate Adenocarcinoma, Ovarian Cancer, Colorectal Adenocarcinoma, Non-small Cell Lung Cancer, Melanoma (Solid Tumor Expansion Arm Only)
    Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) With Concomitant Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM)
    UVA Health Sciences Center Emily Couric Clinical Cancer Center
    Charlottesville, Virginia 22908
    Glioblastoma, GBM, Glioma, High Grade Glioma
    Study of Menstrual Irregularities and Endometrial Pathology in Women Undergoing Bariatric Surgery
    University of Virginia
    Charlottesville, Virginia 22908
    Morbid Obesity, Endometrial Pathology, Menstrual Irregularities
    NBRST: Prospective Neo-adjuvant REGISTRY Trial
    Virginia Breast Care
    Charlottesville, Virginia 22911
    Breast Cancer
    Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
    University of Virginia Healthcare System
    Charlottesville, Virginia 22908
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
    Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Endometrial Cancer
    Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
    University of Virginia
    Charlottesville, Virginia 22908
    Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma
    Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Colorectal Cancer Metastatic
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    University of Virginia
    Charlottesville, Virginia 22908
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    AMR-001 Versus Placebo Post ST Segment Elevation Myocardial Infarction
    UVA Health System Cardiology Research
    Charlottesville, Virginia 22908
    ST Segment Elevation Myocardial Infarction
    Study of Dovitinib (TKI258) in Adenoid Cystic Carcinoma
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Adenoid Cystic Carcinoma
    Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin)
    University of Virginia Health Systems SC-3
    Charlottesville, Virginia 22908-0334
    Advanced NET of GI Origin, Advanced NET of Lung Origin, Neuroendocrine Tumors
    Evaluation Of Mobile Gamma Camera Imaging For Sentinel Node Biopsy In Melanoma
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Melanoma
    Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast Cancer
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Breast Cancer
    Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
    University of Virginia Hospital
    Charlottesville, Virginia 22908
    Melanoma
    Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Unresectable Hepatocellular Carcinoma
    Sodium Management in Acute Neurological Injury
    University of Virginial Health System
    Charlottesville, Virginia 22908
    The Focus of the Study is to Understand the Current Practice of Sodium Management in Patients With Acute Neurological Injury.
    Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
    A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients
    University of Virginia
    Charlottesville, Virginia 22908
    Melanoma
    A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
    Phase 1 Biomarker Study of Anti-PD-1 in Advanced Melanoma
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Advanced Melanoma, Metastatic Melanoma
    Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies
    University of Virginia
    Charlottesville, Virginia 22908
    Hematologic Malignancies
    Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
    University of Virginia
    Charlottesville, Virginia 22908
    Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Safety and Efficacy of CML Patients Who Switch to Nilotinib and Stop Treatment After Achieving and Sustaining MR4.5.
    University of Virginia Hematology/Oncology
    Charlottesville, Virginia 22908
    CML
    NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma
    University of Virginia
    Charlottesville, Virginia 22908
    Unresectable or Metastatic Melanoma
    Efficacy and Safety of TORS for SCCA
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Oropharyngeal Squamous Cell Carcinoma, Supraglottic Squamous Cell Carcinoma
    Shorter Duration Radiotherapy to Treat Prostate Cancer After Removal of the Prostate
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Prostate Cancer
    Phase II Pre-operative Vitamin D Supplementation to Prevent Post-thyroidectomy Hypocalcemia
    University of Virginia
    Charlottesville, Virginia 22908
    Thyroid Nodules, Hypocalcemia
    Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients
    Univ of Virginia Health Sciences Ctr
    Charlottesville, Virginia 22908
    HIV Infections, Chickenpox
    Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Cervical Cancer, Ovarian Cancer
    Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Endometrial Cancer, Psychosocial Effects of Cancer and Its Treatment
    Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Cervical Cancer
    Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
    Cancer Center, University of Virginia HSC

    Trial Locations
    Cancer Center, University of Virginia HSC
    Martha Jefferson Hospital
    Brain and Central Nervous System Tumors
    Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Ovarian Cancer
    Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
    Cancer Center at the University of Virginia

    Trial Locations
    Cancer Center at the University of Virginia
    Martha Jefferson Hospital
    Lung Cancer
    Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
    Cancer Center at the University of Virginia

    Trial Locations
    Cancer Center at the University of Virginia
    Martha Jefferson Hospital
    Prostate Cancer
    Talc in Treating Patients With Malignant Pleural Effusion
    Cancer Center, University of Virginia HSC

    Trial Locations
    Cancer Center, University of Virginia HSC
    Martha Jefferson Hospital
    Metastatic Cancer
    Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
    Cancer Center, University of Virginia HSC

    Trial Locations
    Cancer Center, University of Virginia HSC
    Martha Jefferson Hospital
    Metastatic Cancer